<i>In Vivo</i> Evaluation of the Anticancer Activity of the Gemcitabine and Doxorubicin Combined in a Nanoemulsion. | J Pharm Bioallied Sci;10(1): 35-42, 2018. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

In Vivo Evaluation of the Anticancer Activity of the Gemcitabine and Doxorubicin Combined in a Nanoemulsion.

Alkhatib, Mayson H; Alshehri, Wafa S; Abdu, Faiza B.

Affiliation

Alkhatib MH; Department of Biochemistry, King Abdulaziz University, Jeddah, Saudi Arabia.
Alshehri WS; Department of Biochemistry, King Abdulaziz University, Jeddah, Saudi Arabia.
Abdu FB; Department of Biological Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

J Pharm Bioallied Sci ; 10(1): 35-42, 2018.

Article in En | MEDLINE | ID: mdl-29657506

Key words

Cardiotoxicity; chemotherapeutic agents; mean survival time; z-average diameter; zeta potential

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pharm Bioallied Sci Year: 2018 Document type: Article Affiliation country: Saudi Arabia Country of publication: India

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pharm Bioallied Sci Year: 2018 Document type: Article Affiliation country: Saudi Arabia Country of publication: India